People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zacharon Pharmaceuticals Inc. | — | Pharmaceuticals | Pre-Seed | $500K | $23.7M | 2010 |
| Venquis Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $100K | $2.6M | 2021 |
Robin M Jackman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robin M Jackman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jay B. Lichter | 1 | 3 |
| Court B. Turner | 1 | 2 |
| Raj K Raheja | 1 | 2 |
| Zhiyong K Wang | 1 | 1 |
| Timothy B. Scott | 1 | 1 |
| Douglas J. Cowns | 1 | 1 |
| Charles A. Glass | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.